364 filings
Page 2 of 19
8-K
aq14g24ytpjh
14 Sep 22
BioCryst Names Dr. Bill Sheridan Chief Development Officer and Appoints Dr. Ryan Arnold Chief Medical Officer
4:08pm
8-K
xdmuw0ys
25 Aug 22
Regulation FD Disclosure
7:03am
8-K
yhgtmigksy 9ab7
4 Aug 22
BioCryst Reports Second Quarter 2022 Financial Results and Upcoming Key Milestones
7:06am
8-K
umu43cdod
7 Jun 22
Departure of Directors or Certain Officers
4:53pm
8-K
2oqc2
5 May 22
BioCryst Reports First Quarter 2022 Financial Results and Upcoming Key Milestones
7:05am
8-K
dql0a10zox24berg2
11 Apr 22
Regulation FD Disclosure
8:01am
8-K
sh76 wwng7ci0
8 Apr 22
Other Events
9:17am
8-K
l06k4grh
23 Feb 22
BioCryst Reports Fourth Quarter and Full Year 2021 Financial Results and Upcoming Key Milestones
7:02am
8-K
cs4otaoz5iao0t
22 Feb 22
BioCryst Begins Patient Enrollment in RENEW Proof-of-Concept Trial Evaluating BCX9930 for Patients with Renal Complement-mediated Diseases
7:03am
8-K
fw4856
17 Feb 22
Regulation FD Disclosure
4:05pm
8-K
et2zt911galfft6cf9
8 Feb 22
BioCryst Appoints Machelle Sanders to Board of Directors
7:06am
8-K
905hqkj56mn129zt nh
10 Jan 22
Results of Operations and Financial Condition
7:04am
8-K
6ci9mg8qih9
7 Jan 22
BioCryst Begins Patient Enrollment in REDEEM-1 Pivotal Trial Evaluating BCX9930 as Oral Monotherapy for Patients with PNH
9:34am
8-K
jmy0aviug6hv
29 Nov 21
BioCryst Begins Patient Enrollment in REDEEM-2 Pivotal Trial Evaluating BCX9930 as Oral Monotherapy for Patients with PNH
8:33am
8-K
9z8t95m
22 Nov 21
Entry into a Material Definitive Agreement
7:03am
8-K
3qs4u1i5xd 6o8a46bsu
3 Nov 21
BioCryst Reports Third Quarter 2021 Financial Results and Upcoming Key Milestones
7:04am
8-K
svc bptoky83gmz4
20 Sep 21
BioCryst Appoints Dr. Amy McKee to Board of Directors
7:06am
8-K
0ohfr
1 Sep 21
U.S. Government Exercises Option to Purchase Additional RAPIVABĀ® (peramivir injection) from BioCryst for Delivery to Strategic National Stockpile
7:04am
8-K
uyr7ez6i3t
26 Aug 21
BioCryst Appoints Dr. Steven Galson to Board of Directors
7:05am
8-K
vydlcy5bqg5 aq1m4gfl
9 Aug 21
Departure of Directors or Certain Officers
7:23am